EMBL sells ViraTherapeutics to trade for €210m
Heidelberg-based life sciences VC firm EMBL Ventures has sold its stake in biotechnology company ViraTherapeutics to pharmaceuticals business Boehringer Ingelheim in a transaction valuing the business at €210m.
More on Exits
Nixen sells Weave to trade in €120m deal
Nixen's Weave is wholly acquired by France-based OnePoint, a digital transformation service
Inflexion nets 50% IRR on quick Outdoor Plus exit
Outdoor Plus proved to be a success for Inflexion's minority-stake-focused Partnership Capital fund
Apax France buys AEB Group in SBO
GP eyes a buy-and-build strategy for the Italian food-focused biochemicals business
BPI France sells G2Mobility to trade
French energy giant Total wholly acquires G2mobility, an electric vehicle charging service
Latest News
VC-backed ForceManager buys Sellf
After the acquisition, mobile CRM developer ForceManager will employ around 150 people
Nixen sells Weave to trade in €120m deal
Nixen's Weave is wholly acquired by France-based OnePoint, a digital transformation service
Inflexion nets 50% IRR on quick Outdoor Plus exit
Outdoor Plus proved to be a success for Inflexion's minority-stake-focused Partnership Capital fund
Primary-backed Maru acquires Lissted
Maru Group has acquired local software firm Lissted as part of its acquisition strategy